|
Palmitoyl Tetrapeptide-7
|
棕榈酰四肽-7
|
221227-05-0
|
|
p-NCS-Bn-DOTA
|
2-[(4-异硫氰基苯基)甲基]-1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸
|
127985-74-4
|
|
DOTA-mono-NHStris(t-Buester)
|
DOTA-三叔丁酯-琥珀酰亚胺酯
|
819869-77-7
|
|
pasireotide
|
帕瑞肽
|
396091-73-9
|
|
Octreotide
|
奥曲肽
|
79517-01-4
|
|
Oligonucleotide Synthesis
|
寡合苷酸合成
|
4097-22-7
|
|
2'-F-iBu-dG-CE-Phosphoramidite; 2'-fluoro-N2-isobutyryl-5'-O-(4,4'-dimethoxytrityl)-2'-deoxyguanosine-3'-CE-Phosphoramidite
|
2'-F-dG(iBu) 亚磷酰胺单体
|
144089-97-4
|
|
Maleimido-mono-amide-DOTA
|
|
1006711-90-5
|
|
Angiotensin II (1-4), human
|
血管紧张素II
|
4474-91-3
|
|
Fmoc-Gln(Trt)-Thr(Psi(Me,Me)pro)-OH
|
(4S,5R)-3-[(2S)-2-[[芴甲氧羰基]氨基]-1,5-二氧代-5-[(三苯基甲基)氨基]戊基]-2,2,5-三甲基-4-恶唑烷羧酸
|
1572725-72-4
|
|
Oxytocin Acetate
|
催产素
|
50-56-6
|
|
Eptifibatide
|
依替巴肽
|
188627-80-7
|
|
Peptide fluorescent modification
|
多肽荧光修饰
|
|
|
Copper Peptide
|
三胜肽
|
49557-75-7
|
|
Fmoc-Phe-Val-Gln(Trt)-Trp(Boc)-Leu-Ile-Ala-Gly
|
|
|
|
c(RGDfK)
|
CYCLO (RGDFK)
|
161552-03-0
|
|
5'-O-(4,4-Dimethoxytrityl)-2'-O-methyl-N-isobutyrylguanosine-3'-(2-cyanoethyl-N,N-diisopropyl)phosphoramidite
|
5'-O-(4,4-二甲氧基三苯甲基)-2'-O-甲基-N-异丁酰基鸟苷-3'-(2-氰基乙基-N,N-二异丙基)亚磷酰胺
|
150780-67-9
|
|
Fmoc-Asp(tBu)-Thr[PSI(Me,Me)Pro]-OH
|
(BETAS,4S)-4-羧基-BETA-[[芴甲氧羰基]氨基]-2,2,5-三甲基-GAMMA-氧代-3-恶唑烷丁酸叔丁酯
|
920519-32-0
|
|
Myristoyl Tetrapeptide-12
|
肉豆蔻酰四肽-12
|
959610-24-3
|
|
Biotinoyl tripeptide-1
|
生物素酰三肽-1
|
299157-54-3
|
|
2'-F-Bz-dA-CE-Phosphoramidite; 2'-fluoro-N6-benzoyl-5'-O-(4,4'-dimethoxytrityl)-2'-deoxyadenosine-3'-CE-Phosphoramidite
|
N6-苯甲酰基5'-O-DMT-2'-氟-脱氧腺苷-3'-氰乙氧基亚磷酰胺
|
136834-22-5
|
|
Icatibant
|
艾替班特
|
30308-48-4
|
|
Human GLP-1 (7-36)-NH2
|
胰高血糖素样肽1(7-36)酰胺(人)
|
107444-51-9
|
|
Fmoc-Ile-Ser[PSI(Me,Me)Pro]-OH
|
(4S)-3-[(2S,3S)-2-[[芴甲氧羰基]氨基]-3-甲基-1-氧代戊基]-2,2-二甲基-4-恶唑烷羧酸
|
1147996-34-6
|
|
GLP-1(7-37)
|
人胰高血糖素样肽-1
|
106612-94-6
|
|
Peptide customization
|
多肽定制
|
|
|
DOTA-tris(tBuester)
|
三叔丁基1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸
|
137076-54-1
|
|
Nesiritide
|
奈西利肽
|
124584-08-3
|
|
BocNH-Tyr(tBu)-Aib-Glu(OtBu)-Gly-Thr(tBu)-Phe-Thr(tBu)-Ser(tBu)-Asp(OtBu)-Tyr(tBu)-Ser(tBu)-Ile-Aib-Leu
|
|
|
|
White powder
|
碳酸钙
|
471-34-1
|
|
CNV-38d(1-34)
|
醋酸特立帕肽
|
52232-67-4
|
|
Triptorelin Acetate
|
醋酸曲普瑞林
|
57773-63-4
|
|
Tirzepatide
|
新型双重GIP\GLP-1
|
2023788-19-2
|
|
Fmoc-Val-Thr[PSI(Me,Me)Pro]-OH
|
(4S,5R)-3-[(2S)-2-[[芴甲氧羰基]氨基]-3-甲基-1-氧代丁基]-2,2,5-三甲基-4-恶唑烷羧酸
|
168216-05-5
|
|
DOTA-NHS-ester
|
易吸潮
|
1823122-52-6
|
|
Fmoc-Tyr(tBu)-Thr[PSI(Me,Me)Pro]-OH
|
(4S)-3-[(2S)-3-[4-(叔丁氧基)苯基]-2-[[芴甲氧羰基]氨基]-1-氧代丙基]-2,2,5-三甲基-4-恶唑烷羧酸
|
920519-31-9
|
|
Fmoc-Leu-Thr[PSI(Me,Me)Pro]-OH
|
(5R)-3-[(2S)-2-[[芴甲氧羰基]氨基]-4-甲基-1-氧代戊基]-2,2,5-三甲基-4-恶唑烷羧酸
|
955048-89-2
|
|
Ziconotide acetate
|
齐考诺肽
|
107452-89-1
|
|
2'-F-Bz-dC-CE-Phosphoramidite; N4-benzoyl-5'-O-(4, 4'-dimethoxytrityl)-2'-fluoro-2'-deoxycytidine-3'-CE-Phosphoramidite
|
N4-苯甲酰基-5'-O-DMT-2'-氟-脱氧胞苷-3'-氰乙氧基亚磷酰胺
|
161442-19-9
|
|
Fmoc-Ile-Thr[PSI(Me,Me)Pro]-OH
|
(5R)-3-[(2S,3S)-2-[[芴甲氧羰基]氨基]-3-甲基-1-氧代戊基]-2,2,5-三甲基-4-恶唑烷羧酸
|
957780-52-8
|
|
Fmoc-Thr(tBu)-Ser(Psi(Me,Me)pro)-OH
|
(4S)-3-[(2S,3R)-3-(叔丁氧基)-2-[[芴甲氧羰基]氨基]-1-氧代丁基]-2,2-二甲基-4-恶唑烷羧酸
|
1425938-63-1
|
|
Fmoc-Tyr(tBu)-Ser[PSI(Me,Me)Pro]-OH
|
(4S)-3-[(2S)-3-[4-(叔丁氧基)苯基]-2-[[芴甲氧羰基]氨基]-1-氧代丙基]-2,2-二甲基-4-恶唑烷羧酸
|
878797-09-2
|
|
Fmoc-Trp(Boc)-Thr[PSI(Me,Me)Pro]-OH
|
(5R)-3-[(2S)-3-[1-[叔丁氧羰基]-1H-吲哚-3-基]-2-[[芴甲氧羰基]氨基]-1-氧代丙基]-2,2,5-三甲基-4-恶唑烷羧酸
|
936707-21-0
|
|
Glucagon HCL
|
盐酸胰高血糖素
|
11140-85-5
|
|
polypeptide
|
多肽定制、多肽合成
|
|
|
Fmoc-Gly-Ser[PSI(Me,Me)Pro]-OH
|
(4S)-3-[2-[[芴甲氧羰基]氨基]乙酰基]-2,2-二甲基-4-恶唑烷羧酸
|
1095952-22-9
|
|
Fmoc-Phe-Ser[PSI(Me,Me)Pro]-OH
|
(4S)-3-[(2S)-2-[[芴甲氧羰基]氨基]-1-氧代-3-苯基丙基]-2,2-二甲基-4-恶唑烷羧酸
|
878797-01-4
|
|
2'-F-dU-CE-Phosphoramidite
|
|
|
|
Acetyl Tetrapeptide-5
|
乙酰基四肽-5
|
820959-17-9
|
|
Goserelin
|
戈舍瑞林
|
65807-02-5
|
|
Myristoyl Pentapeptide-17
|
睫毛肽
|
959610-30-1
|
|
Morpholino T subunit; 6-(5-methyl-2, 4-dioxo-3, 4-dihydropyrimidin-1(2H)-yl)-4-ritylmorpholin-2-yl)methyl dimethylphosphoramidochloridate
|
N,N-二甲基氯亚膦酰胺 [(2S,6R)-6-(3,4-二氢-5-甲基-2,4-二氧代-1(2H)-嘧啶基)-4-(三苯基甲基)-2-吗啉基]甲基酯
|
956139-30-3
|
|
Amyloid β-Protein(16-22)
|
Amyloid β-Protein(16-22)
|
153247-41-7
|
|
Adrenomedullin (1-52), human
|
Adrenomedullin (human)
|
148498-78-6
|
|
Pramlintide acetate
|
醋酸普兰林肽
|
196078-30-5
|
|
NOTA-bis(t-Buester)
|
NOTA-BIS(叔丁基酯)
|
1161415-28-6
|
|
Fmoc-Asn(Trt)-Ser[PSI(Me,Me)Pro]-OH
|
(4S)-3-[(2S)-2-[[芴甲氧羰基]氨基]-1,4-二氧代-4-[(三苯基甲基)氨基]丁基]-2,2-二甲基-4-恶唑烷羧酸
|
920519-33-1
|
|
Exenatide acetate
|
醋酸艾塞那肽
|
141732-76-5
|
|
Palmitoyl Pentapeptide-4
|
五胜肽
|
214047-00-4
|
|
Morpholino U subunit
|
|
|
|
Oligonucleotide customization
|
寡核苷酸定制
|
|
|
BocNH-Tyr(tBu)-Aib-Glu(OtBu)-Gly
|
|
|
|
Glucagon - Like Peptide 1, (GLP-1/GLP1) amide, human
|
胰高血糖素样肽1酰胺(人)
|
99658-04-5
|
|
Fmoc-Ala-Ser[PSI(Me,Me)Pro]-OH
|
(4S)-3-[(2S)-2-[[(9H-芴-9-甲氧基)羰基]氨基]-1-氧代丙基]-2,2-二甲基-4-恶唑烷羧酸
|
252554-78-2
|
|
Angiotensin Converting Enzyme Inhibitor
|
替普罗肽
|
35115-60-7
|
|
Morpholino C subunit; 6-(4-benzamido-2-oxopyrimidin-1(2H)-yl)-4-tritylmorpholin-2-yl)methyl Dimethylphosphoramidochloridate
|
|
956139-21-2
|
|
Myristoyl-Hexapeptide-16
|
肉蔻酰六胜肽-16
|
959610-54-9
|
|
Fmoc-Gln(Trt)-Ser[PSI(Me,Me)Pro]-OH
|
FMOC-GLN(TRT)-SER(PSI(ME,ME)PRO)-OH
|
1821378-64-6
|
|
DOTAGA-tetra(tBuester)
|
DOTAGA-四叔丁酯
|
306776-79-4
|
|
Fmoc-Leu-Ser[PSI(Me,Me)Pro]-OH
|
(4S)-3-[(2S)-2-[[芴甲氧羰基]氨基]-4-甲基-1-氧代戊基]-2,2-二甲基-4-恶唑烷羧酸
|
339531-50-9
|
|
5'-O-(4,4-Dimethoxytrityl)-2'-O-methyluridine-3'-(2-cyanoethyl-N,N-diisopropyl)phosphoramidite
|
2'-OMe-U 亚磷酰胺单体
|
110764-79-9
|
|
Ganirelix
|
加尼瑞克
|
123246-29-7
|
|
Custom Peptide
|
客户肽；定制肽；科研肽；多肽定制；多肽合成
|
|
|
Fmoc-Phe-Thr[PSI(Me,Me)Pro]-OH
|
(4S,5R)-3-[(2S)-2-[[芴甲氧羰基]氨基]-1-氧代-3-苯基丙基]-2,2,5-三甲基-4-恶唑烷羧酸
|
1196703-48-6
|
|
Katacalcin
|
钙抑肽
|
85916-47-8
|
|
Glucagon
|
胰高血糖素
|
16941-32-5
|
|
4-Quinolinecarboxamide, N-[2-[(2S)-2-cyano-4,4-difluoro-1-pyrrolidinyl]-2-oxoethyl]-6-[3-(1-piperazinyl)propoxy]-
|
FAPI
|
2471983-20-5
|
|
Leuprorelin
|
亮丙瑞林
|
74381-53-6
|
|
Acetyl tetrapeptide-3
|
乙酰基四肽-3;促眉肽
|
827306-88-7
|
|
Morpholino A subunit; (6-(6-benzamido-9H-purin-9-yl)-4-tritylmorpholin-2-yl) methyl dimethylphosphoramidochloridate
|
N,N-二甲基氯亚膦酰胺 [(2S,6R)-6-[6-(苯甲酰基氨基)-9H-嘌呤-9-基]-4-(三苯基甲基)-2-吗啉基]甲基酯
|
956139-18-7
|
|
GLP-2, human
|
人胰高血糖素样肽2
|
99120-49-7
|
|
Enfuvirtide
|
恩夫韦肽
|
159519-65-0
|
|
Fmoc-Ala-Thr[PSI(Me,Me)Pro]-OH
|
(4S,5R)-3-(N-芴甲氧羰基丙氨酰)-2,2,5-三甲基恶唑烷-4-羧酸
|
252554-79-3
|
|
Peptide synthesis service
|
多肽合成服务
|
|
|
DOTAM-mono-acid
|
DOTAM-MONO-羧酸试剂;4,7,10-三(2-氨基-2-氧乙基)-1,4,7,10-四氮杂环十二烷-1-乙酸;
|
913528-04-8
|
|
Antide
|
安替肽
|
112568-12-4
|
|
Thymosin alpha 1
|
胸腺肽α1
|
62304-98-7
|
|
Pal-Tripeptide-1
|
棕榈酰三肽-1
|
147732-56-7
|
|
Morpholino G subunit
|
|
|
|
DOTAM-NHS-ester
|
|
2236057-47-7
|
|
Fmoc-Asp(OtBu)-Lys(Boc)-Ile-Ala-Gln(Trt)-Lys[C20-OtBu-Glu(OtBu)-AEEA-AEEA]-Ala
|
|
|
|
2'-OMe-Bz-C-CE-Phosphoramidite; N4-benzoyl-5'-O-(4,4'-Dimethoxytrityl)-2'-O-methyl-Cytidine-3'-CE-Phosphoramidite
|
2'-OMe-Bz-C 亚磷酰胺单体
|
110764-78-8
|
|
Syn-AKE
|
类蛇毒三肽
|
823202-99-9
|
|
Leuprolide
|
醋酸亮丙瑞林
|
53714-56-0
|
|
Maleimido-mono-amide-NOTA
|
Maleimido-mono-amide-NOTA
|
1295584-83-6
|
|
H2N-Gly-Pro-Ser(tBu)-S(tBu)-Gly-Ala-Pro-Pro-Pro-S(tBu)-CONH2
|
|
|
|
2'-O-Methyl-rA(N-Bz)phosphoramidite
|
2'-OMe-A(Bz) 亚磷酰胺单体;N-苯甲酰基-5'-O-(4,4-二甲氧基三苯甲基)-2'-O-甲基腺苷-3'-(2-氰基乙基-N,N-二异丙基)亚磷酰胺
|
110782-31-5
|
|
Fmoc-Val-Ser[PSI(Me,Me)Pro]-OH
|
(4S)-3-[(2S)-2-[[芴甲氧羰基]氨基]-3-甲基-1-氧代丁基]-2,2-二甲基-4-恶唑烷羧酸
|
186023-49-4
|
|
NOTAGA-tris(t-Buester)
|
(R)-NODA-GA(tBu)3
|
438553-50-3
|
|
(S)-6-[3-(4-Boc-1-piperazinyl)propoxy]-N-[2-(2-cyano-4,4-difluoro-1-pyrrolidinyl)-2-oxoethyl]quinoline-4-carboxamide
|
(S)-6-[3-(4-Boc-1-哌嗪基)丙氧基]-N-[2-(2-氰基-4,4-二氟-1-吡咯烷基)-2-氧代乙基]喹啉-4-甲酰胺
|
2374782-82-6
|
|
Fmoc-Lys(Boc)-Ser[PSI(Me,Me)Pro]-OH
|
(4S)-3-[(2S)-6-[[叔丁氧羰基]氨基]-2-[[芴甲氧羰基]氨基]-1-氧代己基]-2,2-二甲基-4-恶唑烷羧酸
|
957780-54-0
|